Antiplatelet drugs

The U.S. Food and Drug Administration ( FDA ) has approved once-daily Yosprala, the only prescription fixed-dose combination of Aspirin,...


The European Society of Cardiology ( ESC ) has recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device...


Patients with a high-risk Paclitaxel drug-eluting stent who were given the shorter-acting antiplatelet drug Cilostazol ( Pletal ) prior to...


The FDA ( Food and Drug Administration ) has approved Kengreal ( Cangrelor ), an intravenous antiplatelet drug that prevents...


Oral anticoagulation therapy ( OAT ) is the choice treatment for thromboembolism prevention in atrial fibrillation ( AF ), although...


In February 2014, the American Heart Association [ AHA ] /American Stroke Association [ ASA ] released their first guideline...


Clopidogrel ( Plavix ) is a platelet aggregation inhibitor indicated for conditions such as myocardial infarction, stroke or established peripheral...


The Resolute Integrity stent is a metal stent with the drug Zotarolimus contained in a thin coating on the stent’s...


MHRA ( Medicines and Healthcare Products Regulatory Agency ) previously advised that the contraindications for Dabigatran ( Pradaxa ) had...


Treatment with Prasugrel ( Efient, Effient ) and Acetylsalicylic acid ( Aspirin ) improves outcomes compared with Clopidogrel ( Plavix...


Results of a phase III clinical trial has shown that a simple drug regimen of two anti-clotting drugs, Clopidogrel (...


In order to better prevent blood clots, Clopidogrel ( Plavix ) can be prescribed to patients with acute ischaemia of...


Heightened platelet activity plays a critical role in thrombus formation, which is central to acute coronary syndromes ( ACS ),...


Patients with myocardial infarction who stopped taking antiplatelet drugs within 30 days of receiving a drug-coated stent had nine times...


Data from the PROactive Study, presented at the 41st meeting of the European Association for the Study of Diabetes (...


Study treatments for the ACTIVE W trial of the ACTIVE ( Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of...


Aspirin and Clopidogrel ( Plavix ) are platelet antiaggregant drugs widely used and proven to be effective in the treatment...